Nanjing Hicin Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 260.64 million compared to CNY 265.11 million a year ago. Revenue was CNY 261.55 million compared to CNY 267.58 million a year ago.

Net income was CNY 19.47 million compared to CNY 17.72 million a year ago. Basic earnings per share from continuing operations was CNY 0.1623 compared to CNY 0.1477 a year ago. Diluted earnings per share from continuing operations was CNY 0.1623 compared to CNY 0.1477 a year ago.